Stay updated on Sitravatinib in Advanced Liposarcoma and Soft Tissue Sarcomas Clinical Trial
Sign up to get notified when there's something new on the Sitravatinib in Advanced Liposarcoma and Soft Tissue Sarcomas Clinical Trial page.

Latest updates to the Sitravatinib in Advanced Liposarcoma and Soft Tissue Sarcomas Clinical Trial page
- Check6 days agoChange DetectedAdded Revision: v3.4.2 and removed prior notices about government funding lapse and operating status, including removal of Revision: v3.4.1.SummaryDifference0.5%

- Check13 days agoChange DetectedA site-wide funding notice was added and the revision label updated from v3.4.0 to v3.4.1.SummaryDifference0.5%

- Check20 days agoChange DetectedShow glossary added. Study Protocol and Statistical Analysis Plan PDF added to Study Documents, with updated Last Verified and Results First Posted dates.SummaryDifference46%

- Check34 days agoChange DetectedThe page revision updated from v3.3.3 to v3.3.4, indicating a minor metadata update; no trial content, eligibility criteria, locations, or outcomes appear affected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check49 days agoChange DetectedThe page now displays a Locations section with sites in Massachusetts, Missouri, and New York, and the HHS Vulnerability Disclosure link was removed.SummaryDifference0.5%

- Check77 days agoChange DetectedRevision updated from v3.3.1 to v3.3.2, indicating a minor version change with no impact on study information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Sitravatinib in Advanced Liposarcoma and Soft Tissue Sarcomas Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sitravatinib in Advanced Liposarcoma and Soft Tissue Sarcomas Clinical Trial page.